Automating Biopharma Manufacturing

PharmaTech

Automation and digitalization work together in the digital plant.

An Integrated Approach to the Data Lifecycle in BioPharma

PharmaTech

Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.

Roche to acquire biopharma firm Good Therapeutics for $250m

Pharmaceutical Technology

The post Roche to acquire biopharma firm Good Therapeutics for $250m appeared first on Pharmaceutical Technology. Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of $250m in cash.

Novo Nordisk agrees to acquire biopharma firm Forma for $1.1bn

Pharmaceutical Technology

The post Novo Nordisk agrees to acquire biopharma firm Forma for $1.1bn appeared first on Pharmaceutical Technology.

Biopharma has a brand new target: Cancer-specific collagen

MedCity News

BioPharma Daily SYN Top Story cancer MD Anderson Cancer Center oncology pancreatic cancerResearchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate.

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

PharmExec

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.

How resilient is the global biopharma industry?

Pharmaceutical Technology

As the full consequences of the COVID-19 virus started to emerge, and many industries found themselves having to either suspend operations or move to remote working, the biopharma sector found itself on the front line facing unprecedented challenges.

Pace Life Sciences Purchases Biopharma Global

Pharmaceutical Commerce

Allows CDMO’s regulatory, consulting services to further expand into the pharma market.

Amgen to acquire biopharma firm ChemoCentryx for $3.7bn

Pharmaceutical Technology

The post Amgen to acquire biopharma firm ChemoCentryx for $3.7bn appeared first on Pharmaceutical Technology. Amgen has signed a definitive agreement to acquire biopharmaceutical company ChemoCentryx for $52 for each share in cash or a total enterprise cost of nearly $3.7bn.

Genfit agrees to acquire biopharma firm Versantis for $109m

Pharmaceutical Technology

The post Genfit agrees to acquire biopharma firm Versantis for $109m appeared first on Pharmaceutical Technology.

Accelerating Time-to-Insight Throughout the BioPharma Lifecycle

PharmaTech

Innovation is driven through a strong digital backbone.

Biopharma firm Radius Health is going private in an $890M M&A deal

MedCity News

BioPharma Daily Pharma SYN Top Story biopharma nl Boston cancer deals F-star Therapeutics life sciences M&A osteoporosis Radius Health Tymlos

Hetero Biopharma-Walk-In Interviews for Production/ Quality Control On 23rd Sept’ 2022

Pharma Pathway

Hetero Biopharma-Walk-In Interviews for Production/ Quality Control On 23rd Sept’ 2022. Greetings from Hetero Biopharma !!! Walk-In Interviews for Freshers & Experienced in Production/ Quality Control On 23rd Sept’ 2022@ Hetero Biopharma.

Trends in biopharma contract manufacturing 2022

European Pharmaceutical Review

Pharma contract manufacturing market to grow to $130bn by 2026… The post Trends in biopharma contract manufacturing 2022 appeared first on European Pharmaceutical Review According to a recent survey , 86.9

Navigating the Financial Meltdown for Biopharma

PharmExec

A review of pharma and biotech equity market, IPO, and M&A trends and outputs through the first half of 2022—and implications for the future as disruptions continue to have an impact.

With $453M in realized pay in 2021, Regeneron's Schleifer was biopharma's best-paid CEO: Stat

Fierce Pharma

With $453M in realized pay in 2021, Regeneron's Schleifer was biopharma's best-paid CEO: Stat. Mon, 07/18/2022 - 10:29

Protecting the supply chain: Why biopharma needs integrated workflows

Pharmaceutical Technology

This higher level of interdependence is due to the rapid growth rate of technology development within the biopharma and pharmaceutical industries. The post Protecting the supply chain: Why biopharma needs integrated workflows appeared first on Pharmaceutical Technology.

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

Pharma Leaders

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions. Compliance Channel Posts

Global Biopharma Launches in the New World Order

PM360

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Biopharma organizations are adjusting their approaches to development and commercialization.

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

PharmaTech

Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.

Traditional approaches to growth in biopharma are no longer sustainable

Pharma Phorum

Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace.

Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy

PharmaTech

In this episode of the Drug Solutions Podcast, John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals shares outsourcing strategies in biopharma.

Ipsen beefs up in oncology, buying US biopharma Epizyme

Pharma Phorum

The post Ipsen beefs up in oncology, buying US biopharma Epizyme appeared first on. The revamp of French drugmaker Ipsen has continued with a takeover agreement for US counterpart Epizyme and its cancer therapy Tazverik, in a deal valued at a little under $250 million. Ipsen is offering $1.45

Pfizer signs agreement to acquire biopharma firm GBT for $5.4bn

Pharmaceutical Technology

The post Pfizer signs agreement to acquire biopharma firm GBT for $5.4bn appeared first on Pharmaceutical Technology.

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

PharmaTech

The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials.

Setting sights on suppliers: How biopharma is tackling the environment in its ESG commitments

Fierce Pharma

Setting sights on suppliers: How biopharma is tackling the environment in its ESG commitments. fkansteiner. Wed, 07/13/2022 - 12:52

POINT Biopharma announces appointment of Chris Horvath as EVP, Commercial

PharmExec

Horvath, who brings over a decade of experience in pharmaceutical commercialization, will lead the commercialization of POINT’s pipeline.

invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m

Pharmaceutical Technology

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12

Syner-G Biopharma Group Appoints Ron Kraus as CEO

PharmExec

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

Oregon Freeze Dry Opens $7.5 Million Biopharma Facility

Pharmaceutical Commerce

New facility will provide lyophilization services.

Oregon Freeze Dry Opens $7.5 Million Biopharma Facility

PharmaTech

The new facility in Albany, Ore., will support biopharmaceutical development and lyophilization services.

DuPont Opens Biopharma Tubing Manufacturing Site in South Carolina

PharmaTech

DuPont’s new manufacturing site will expand its biopharmaceutical tubing manufacturing capabilities.

'The Top Line' podcast: The highest paid biopharma CEOs , Merck, Seagen acquisition plus this week's headlines

Fierce Pharma

The Top Line' podcast: The highest paid biopharma CEOs , Merck, Seagen acquisition plus this week's headlines. tcarey. Thu, 07/14/2022 - 14:39

A Steadying Force in C-Suite: The Changing Role of Biopharma CFOs

PharmExec

COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog.

Manvi Biopharma Pvt. Ltd-Walk-In Interviews for Production/ QA/ QC/ R&D/ AR&D/ Purchase/ Warehouse/ HR On 2nd to 5th Sept’ 2022

Pharma Pathway

Manvi Biopharma Pvt. Walk-In Interviews for Production/ QA/ QC/ R&D/ AR&D/ Purchase/ Warehouse/ HR On 2nd to 5th Sept’ 2022 @ Manvi Biopharma Pvt. Venue: Manvi Biopharma Pvt. Manvi Biopharma Pvt.

MassBio releases Industry Snapshot, Reveals Strong Performance in Massachusetts-Headquartered BioPharma Companies

PharmExec

Companies headquartered in the state raised the fourth highest annual total in the first half of this year.

The patient privacy factor in clinical trials

MedCity News

BioPharma Daily Health IT Legal MedCity Influencers SYN Top Story biopharma nl Clinical Trials patient privacyIn the first quarter of 2022, my personal life converged with my work life concerning […].

White matter could have more clues about Alzheimer’s than previously thought, Mount Sinai researchers say

MedCity News

BioPharma Daily Health Tech SYN Top Story Alzheimers biopharma nl cognitive decline machine learning Mount Sinai neuroscience

Disappointing data lead Pfizer to drop heart drug acquired as part of $11B deal

MedCity News

billion acquisition of Array Biopharma in 2019. BioPharma Daily News Pharma SYN Top Story Array Biopharma biopharma nl Clinical Trials heart disease Pfizer rare disease

Leads 92

Designing an Effective Biopharma Payout Curve – Part 3: Setting Thresholds & Slopes

The Marketing Advantage

June 27, 2022 The payout curve against which a sales force is compensated has tremendous ability to motivate the sales force to drive sales—so much so that we are dedicating a three-part series to biopharma payout curve design.